Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy

Yang Liu, Jie Yang, Fenghua Yu, Li Li, Ning Zhao, Cheng Lu*, Aiping Lu*, Xiaojuan He*

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

Abstract

Hepatocellular carcinoma (HCC) has a relatively poor prognosis and a high degree of malignancy. However, the therapeutic drugs are limited. In recent years, abnormal lipid metabolism and its important role in HCC has been reported, and emerging studies found that some formulae and active components of traditional Chinese medicine (TCM) can regulate abnormal lipid metabolism in HCC, showing their good application prospects. Therefore, this article summarizes the changes and the roles of lipid metabolites in HCC progression, and discusses the role of formulae and active components of TCM for the treatment of HCC based on their regulation on abnormal lipid metabolism. A deeper understanding of their relationship may help the precise use of these formulae and active components in HCC.

Original languageEnglish
Article number1528671
Number of pages16
JournalFrontiers in Pharmacology
Volume16
DOIs
Publication statusPublished - 25 Apr 2025

User-Defined Keywords

  • active components
  • formulae
  • hepatocellular carcinoma
  • lipid metabolism
  • traditional Chinese medicine

Fingerprint

Dive into the research topics of 'Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy'. Together they form a unique fingerprint.

Cite this